Literature DB >> 11090519

ABC of colorectal cancer: effectiveness of follow up.

C McArdle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11090519      PMCID： PMC1119069          DOI： 10.1136/bmj.321.7272.1332

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 2.  Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Authors:  Mark Jeffery; Brigid E Hickey; Phil N Hider; Adrienne M See
Journal:  Cochrane Database Syst Rev       Date:  2016-11-24

3.  Jagged 2 silencing inhibits motility and invasiveness of colorectal cancer cell lines.

Authors:  Wan He; Charles Ming Lok Chan; Sze Chuen Cesar Wong; Thomas Chi Chuen Au; Wing Shan Ho; Amanda Kit Ching Chan; Andrew Sai Kit Chan; Brigette Buig Yue Ma; Anthony Tak Cheung Chan
Journal:  Oncol Lett       Date:  2016-10-26       Impact factor: 2.967

4.  Prognostic value of chemotherapy-induced hematological toxicity in metastatic colorectal cancer patients.

Authors:  Laurie Rambach; Aurelie Bertaut; Julie Vincent; Veronique Lorgis; Sylvain Ladoire; Francois Ghiringhelli
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

5.  Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance.

Authors:  Hartwig Körner; Kjetil Söreide; Pål J Stokkeland; Jon Arne Söreide
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

6.  Follow-up recommendations for colon cancer.

Authors:  W Donald Buie; Jo-Anne P Attard
Journal:  Clin Colon Rectal Surg       Date:  2005-08

7.  Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases.

Authors:  L J M Mekenkamp; M Koopman; S Teerenstra; J H J M van Krieken; L Mol; I D Nagtegaal; C J A Punt
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

8.  Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.

Authors:  Bogdan Zalewski
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

9.  Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Authors:  Mark Jeffery; Brigid E Hickey; Phillip N Hider
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04

10.  Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice.

Authors:  L G E M Razenberg; Y R B M van Gestel; I H J T de Hingh; O J L Loosveld; G Vreugdenhil; L V Beerepoot; G J Creemers; V E P P Lemmens
Journal:  BMC Cancer       Date:  2016-02-16       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.